Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
ICLL began a placebo-controlled, Swedish Phase I trial of HyVac4 in 64 individuals vaccinated with Bacillus of Calmette and Guerin (BCG) vaccine. ICLL is co-developing HyVac4 with Aeras Global TB Vacc...